UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	February 3, 2021

Accession Number:	0000882104-21-000026
Submission Type:	POS AM
CIK: 0000882104 Company Name: PDL BIOPHARMA, INC. File Number: 333-220370